ANI Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 237.5M | 247.1M | 227.8M | 211.4M | 197.1M | 190.6M | 148.3M | 138.0M |
| Cost of Goods Sold | 114.5M | 9.5M | 116.0M | 74.6M | 73.0M | 80.3M | 63.1M | 57.7M |
| Gross Profit | 123.0M | 237.6M | 111.8M | 136.8M | 124.1M | 110.3M | 85.3M | 80.3M |
| R&D Expenses | 10.6M | 12.3M | 12.3M | 16.5M | 10.6M | 16.6M | 10.1M | 7.3M |
| Operating Expenses | 84.3M | 189.4M | 89.0M | 122.9M | 97.9M | 114.7M | 105.8M | 75.2M |
| Operating Income | 38.7M | 48.2M | 22.8M | 13.9M | 26.2M | -4.4M | -20.5M | 5.2M |
| Other Income / Gains | 1.5M | -16.7M | 11.0M | -3.4M | -6.2M | -9.4M | -11.0M | -7.5M |
| Net Income | 29.5M | 27.5M | 24.1M | 8.5M | 15.7M | -10.3M | -24.2M | -2.3M |
| EPS (Diluted) | 1.31 | 1.24 | 1.19 | 0.37 | 0.70 | -0.55 | -1.27 | -0.14 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.518 | 0.962 | 0.491 | 0.647 | 0.629 | 0.579 | 0.575 | 0.582 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 73.7M | 82.8M | 76.7M | 81.8M | 76.5M | 69.7M | 79.1M | 52.8M |
| Other Expenses | 0 | 94.3M | 0 | 24.6M | 10.8M | 28.3M | 16.6M | 15.1M |
| Cost And Expenses | 198.8M | 198.9M | 205.0M | 197.5M | 170.9M | 195.0M | 168.9M | 132.9M |
| Interest Income | 0 | 5.4M | 0 | 2.8M | 2.6M | 0 | 0 | 0 |
| Interest Expense | -3.8M | 22.8M | 4.7M | 8.2M | 8.1M | 6.0M | 2.3M | 4.7M |
| Depreciation And Amortization | 20.9M | 22.6M | 22.6M | 23.3M | 22.9M | 22.6M | 15.7M | 14.7M |
| Ebitda | 57.4M | 76.9M | 61.2M | 39.2M | 48.4M | 14.9M | -13.4M | 17.1M |
| Ebitdaratio | 0.242 | 0.311 | 0.268 | 0.186 | 0.245 | 0.078 | -0.09 | 0.124 |
| Operating Income Ratio | 0.163 | 0.195 | 0.10 | 0.066 | 0.133 | -0.023 | -0.138 | 0.037 |
| Income Before Tax | 40.2M | 31.5M | 33.8M | 10.5M | 20.0M | -13.8M | -31.5M | -2.3M |
| Income Before Tax Ratio | 0.169 | 0.127 | 0.148 | 0.05 | 0.101 | -0.072 | -0.212 | -0.017 |
| Income Tax Expense | 10.7M | 4.0M | 7.2M | 2.0M | 4.3M | -3.5M | -7.3M | 0 |
| Net Income Ratio | 0.124 | 0.111 | 0.106 | 0.04 | 0.08 | -0.054 | -0.163 | -0.017 |
| Epsdiluted | 1.28 | 1.17 | 1.13 | 0.36 | 0.69 | -0.55 | -1.27 | -0.14 |
| Weighted Average Shs Out | 20.9M | 20.1M | 20.1M | 19.8M | 19.6M | 19.4M | 19.4M | 19.3M |
| Weighted Average Shs Out Dil | 21.5M | 21.2M | 21.1M | 20.3M | 20.0M | 19.4M | 19.4M | 19.3M |